Literature DB >> 31517953

Investigation and management of a large community mumps outbreak among young adults in Toronto, Canada, January 2017-February 2018.

V Dubey1,2, O Ozaldin1, L Shulman1, R Stuart1, J Maclachlan1, L Bromley1, A Summers2.   

Abstract

BACKGROUND: In 2017, a mumps outbreak was identified in a cohort of 18-34 year olds in Toronto, Canada.
OBJECTIVE: To describe a large community mumps outbreak in an urban centre from January 2017 to February 2018 among young adults.
METHODS: A broad range of interventions were implemented in an attempt to reach the target audience; including case and contact management, vaccination clinics at schools and clinicians' offices, school exclusions, bar inspections, traditional communication strategies (including health care provider updates and posters) and newer communication strategies (including three sequential social media campaigns).
RESULTS: A total of 143 cases of mumps were identified. Although cases' ages ranged from three to 72 years, most (76%) were 18-34 year olds, many of whom had frequented bars and local food establishments in downtown Toronto. 84% (n=120) of the cases were community-acquired. Only 16% (n=23) of the cases reported exposures in schools and post-secondary school institutions. Of those, 39% (n=56) of cases had an unknown vaccination history; 34% (n=49) were either not vaccinated or partially vaccinated with one dose of measles-mumps-rubella vaccine; and 27% (n=38) had received the recommended two doses of mumps vaccine. Determining vaccination status was a challenge, in part due to the lack of a registry. Vaccination was recommended when subjects were known to have had fewer than two doses of vaccine or had an unknown vaccination status. A social media campaign, emphasizing the risk of social activities if not protected from the mumps, yielded over 500,000 impressions from Facebook and Twitter messages and ads and an impressive engagement rate of between 1% and 10x%.
CONCLUSION: This was the largest mumps outbreak in Toronto in over 20 years. Among young adults, ongoing social media and traditional communication campaigns can contribute to the control of community mumps outbreaks. Encouraging vaccine uptake is desirable, but without a vaccine registry it is difficult to assess vaccination coverage among adults. Susceptible cohorts of young adults who were not adequately vaccinated pose a risk for future outbreaks. Given that almost 30% of the mumps cases were fully vaccinated with two doses of mumps-containing vaccine, even two doses may not provide complete protection.

Entities:  

Keywords:  MMR; Toronto; mumps; mumps vaccine; outbreak; social media; vaccine coverage; vaccine registry; young adults

Year:  2018        PMID: 31517953      PMCID: PMC6707419          DOI: 10.14745/ccdr.v44i12a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  7 in total

1.  Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults.

Authors:  Gaynor Watson-Creed; Andrea Saunders; Jeffrey Scott; Luis Lowe; Janice Pettipas; Todd F Hatchette
Journal:  CMAJ       Date:  2006-08-29       Impact factor: 8.262

2.  An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.

Authors:  Shelley L Deeks; Gillian H Lim; Mary Anne Simpson; Louise Gagné; Jonathan Gubbay; Erik Kristjanson; Cecilia Fung; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-05-16       Impact factor: 8.262

3.  Guidelines for the Prevention and Control of Mumps Outbreaks in Canada.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-01-04

4.  Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015-2016.

Authors:  Justin P Albertson; Whitney J Clegg; Heather D Reid; Benjamin S Arbise; Julie Pryde; Awais Vaid; Rachella Thompson-Brown; Fredrick Echols
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-07-29       Impact factor: 17.586

5.  Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak.

Authors:  Mona Marin; Mariel Marlow; Kelly L Moore; Manisha Patel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-12       Impact factor: 17.586

6.  Impact of a social media campaign targeting men who have sex with men during an outbreak of syphilis in Winnipeg, Canada.

Authors:  C Ross; S Shaw; S Marshall; S Stephen; K Bailey; R Cole; J Wylie; J Bullard; P Van Caeseele; J Reimer; P Plourde
Journal:  Can Commun Dis Rep       Date:  2016-02-04

7.  Notes from the Field: Absence of Asymptomatic Mumps Virus Shedding Among Vaccinated College Students During a Mumps Outbreak - Washington, February-June 2017.

Authors:  Jesse Bonwitt; Vance Kawakami; Adam Wharton; Rachel M Burke; Neil Murthy; Adria Lee; BreeAnna Dell; Meagan Kay; Jeff Duchin; Carole Hickman; Rebecca J McNall; Paul A Rota; Manisha Patel; Scott Lindquist; Chas DeBolt; Janell Routh
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-12-01       Impact factor: 17.586

  7 in total
  4 in total

1.  A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax).

Authors:  Noni E MacDonald; Eve Dubé
Journal:  Can Commun Dis Rep       Date:  2020-01-02

2.  Mumps outbreaks across Canada, 2016 to 2018.

Authors:  Myriam Saboui; Susan G Squires
Journal:  Can Commun Dis Rep       Date:  2020-11-05

Review 3.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

4.  Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada.

Authors:  Wallis Rudnick; Sarah Wilson; Jo Ann Majerovich; Michelle Haavaldsrud; Marene Gatali; Cai-Lei Matsumoto; Shelley Deeks
Journal:  Hum Vaccin Immunother       Date:  2021-07-22       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.